Website & contact details
- Website
Enterprise Therapeutics Ltd
- Incorporated
- 2 May 2014 (12 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Accounts type
- Full
- Region
- South East
- Address
- Sussex Innovation Centre Science Park SquareFalmerBrightonBN1 9SB
Filing status
- Accounts due
- 31 March 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 16 May 2027
- Last conf. stmt
- 2 May 2026
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 2 active
Officer details are public data from the Companies House register.
Boyd, Philip James, Dr
Secretary · Appointed 15 December 2016
Director · Appointed 3 November 2016
British
Born July 1974 (52)
Officer history (15 former)
20 May 2021
20 May 2021
20 May 2021
20 May 2021
20 May 2021
20 May 2021
Resigned Mulder, Geert-Jan as Director
1 January 2020
1 January 2020
Resigned Morris, David as Director
10 September 2019
10 September 2019
2 April 2019
2 April 2019
Resigned Roper, Elizabeth as Director
6 April 2018
6 April 2018
6 April 2018
Appointed Mulder, Geert-Jan as Director
6 April 2018
Appointed Morris, David as Director
6 April 2018
Resigned Gosling, Martin, Dr as Director
6 April 2018
15 February 2018
15 February 2018
15 December 2016
Appointed Boyd, Philip James, Dr as Secretary
3 November 2016
5 May 2015
8 December 2014
Resigned Danahay, Henry, Dr as Director
8 December 2014
8 December 2014
Resigned Mccarthy, Clive, Dr as Director
8 December 2014
Resigned Storey, John Mervyn David, Professor as Director
8 December 2014
Appointed Roper, Elizabeth as Director
2 May 2014
Appointed Danahay, Henry, Dr as Director
2 May 2014
Appointed Mccarthy, Clive, Dr as Director
2 May 2014
Appointed Storey, John Mervyn David, Professor as Director
2 May 2014
Appointed Gosling, Martin, Dr as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 5 October 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporate
Reg. no. 12868901
Former controllers (3)
5 October 2020
Ceased Ip2ipo Portfolio (GP) Limited — Owns 25–50% of shares
5 October 2020
Ceased Touchstone Innovations Businesses LLP — Owns 25–50% of shares
6 April 2018
Ceased Epidarex Capital Partners Limited — Owns 25–50% of shares
Financials
Figures from 2025 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Profit
- (£4,324,207)
- Employees
- 9
Trend
Employees
Balance sheet detail
| 2025 | 2024 | 2021 | 2020 | |
|---|---|---|---|---|
| Current Assets | £7,246,311 | £10,400,640 | £3,220,540 | £7,018,901 |
| Turnover | £1,077,612 | |||
| Staff Costs | £1,047,938 | £2,018,387 | £1,906,982 | £1,634,969 |
| Profit for Period | (£4,324,207) | (£7,215,668) | (£4,189,789) | (£5,863,268) |
Filings 106
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 14 August 2026 | Previous accounting period shortened | |||
| 8 May 2026 | Confirmation statement with no updates | 2 May 2026 | ||
| 18 April 2026 | Full accounts | 31 December 2025 | ||
| 2 January 2026 | Previous accounting period shortened | |||
| 8 September 2025 | Full accounts | 30 June 2025 |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →